XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESEARCH AND DEVELOPMENT COLLABORATIVE AGREEMENTS (Tables)
 9 Months Ended
Sep. 30, 2013
RESEARCH AND DEVELOPMENT COLLABORATIVE AGREEMENTS  
Schedule of recognized revenue under the Pfizer agreement

 

 

Nine Months Ended

 

Three Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2013

 

2012

 

2013 

 

2012

 

Cost reimbursements

 

$

—

 

$

1,916,250

 

$

—

 

$

—

 

Amortization of license and development fees

 

4,336,036

 

2,826,920

 

1,845,021

 

1,060,057

 

 

 

$

4,336,036

 

$

4,743,170

 

$

1,845,021

 

$

1,060,057